September 14, 2021 12:42 am Published by admin Study Description Go to Brief Summary: This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body’s [...]
September 9, 2021 5:11 pm Published by admin Last Notice Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) This Event is Free to All that Register Join Us for This Very Informative Event https://csfshayma.org/virtual-dialogue3-registration/ The Chondrosarcoma CS Foundation, Inc. will [...]
August 31, 2021 4:57 pm Published by admin The Chondrosarcoma Foundation is hosting its first fundraising event to bring awareness to Chondrosarcoma: a rare bone and soft tissue cancer. Where: The comfort of your own neighborhood! When: anytime between October 3rd-9th TO LEARN MORE AND REGISTER, CLICK HERE Recruit and Create your 5k Walk or Run where ever you live. Take pictures and [...]
August 11, 2021 2:38 am Published by admin https://www.eventbrite.com/e/steppin-for-a-cause-tickets-166736518415
August 10, 2021 2:00 am Published by admin The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma Survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing information to help Chondrosarcoma patients make informed decisions to take charge of their care. Christian Meyer, M.D., Ph.D. is the [...]
August 9, 2021 5:23 pm Published by admin Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist For more information: Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist | Molecular Cancer Therapeutics (aacrjournals.org) Vivek Subbiah, Robert E. Brown, Jamie Buryanek, Jonathan Trent, Avi Ashkenazi, Roy Herbst [...]
August 1, 2021 9:55 pm Published by admin Did you know… Research initiated by the Bone Cancer Research Trust discovered that navigation guided surgery improves 5-year chondrosarcoma-specific survival from 53% to 76%! Read about this life-saving breakthrough and many more in our new report ‘15 Years of Research – Working Towards a Cure’. Access the report now: http://ow.ly/egtT50FyNs7 #15YearsOfResearch #SarcomaAwareness #UntilTheresACure
August 1, 2021 4:26 pm Published by admin Chondrosarcoma CS Foundation, Inc.Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) Join Us for This Very Informative Event https://csfshayna.org/virtual-dialogue3-registration The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel [...]
July 30, 2021 2:24 pm Published by admin James W. Snider, M.D. World Renown Radiation Oncologist will Address Proton and Radiation Treatment at Virtual Dialogue Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) The Chondrosarcoma CS Foundation, Inc. will host [...]
July 30, 2021 12:20 am Published by admin Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma survivors and prominent experts to [...]
